The markets opened lower with the Dow falling 49 points to 19,777 as President Donald Trump withdraws from the Trans-Pacific Partnership. Nasdaq lost 10 points to 5,544.
On the upside
Marinus Pharmaceuticals (Nasdaq: MRNS) reported positive preliminary results from an ongoing Phase 2 open-label study of ganaxolone to treat the severe, rare genetic disorder CDKL5.
The Food and Drug Administration granted 510(k) clearance for commercial distribution to Biolase's (Nasdaq: BIOL) Epic Pro laser system.
Cynosure (Nasdaq: CYNO) is exploring strategic options including a possible sale of the company.
On the downside
Apple (Nasdaq: AAPL) filed a $1 billion lawsuit against Qualcomm (Nasdaq: QCOM) for using anticompetitive practices.
An independent investigation by a Special Committee determined that Banc of California (NYSE: BANC) made inaccurate statements in a press release dated October 18, 2016.
Nordic American Tankers (NYSE: NAT) declared a quarterly dividend of 20 cents per share payable on February 24, 2017 to shareholders of record February 10, 2017.
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 5 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 index lost 3 points to 2,268. Bitcoin added $5 to $920.
